期刊文献+

肝肺综合征的CT表现及临床意义 被引量:2

CT Findings and Clinical Significance in Hepatopulmonary Syndrome
下载PDF
导出
摘要 目的 :探讨肝肺综合征 (hepatopulmonarysyndrome ,HPS)的CT表现及临床意义。材料和方法 :对 3 9例经临床、实验室和影像学检查证实为失代偿期肝硬化 (decompensationcirrhosis ,DCC)并发HPS ,40例正常对照组的CT扫描结果以及 2例DCC并发HPS的肺动脉DSA结果进行分析。观察 :右肺底最大肺纹理的直径 ;右肺底平均密度 ;右下肺末梢肺纹理延伸至胸膜面的发生率。结果 :右肺底最大肺纹理的直径 ,病例组 ( 0 .44± 0 .0 9mm)高于对照组 ( 0 .3 1± 0 .0 8mm ,P <0 .0 1) ;病例组右肺底平均密度 ( -671.4± 92 .4Hu)大于对照组 ( -710 .1± 5 4.7Hu ,P <0 .0 5 ) ;右下肺末梢肺纹理延伸至胸膜面的发生率病例组 ( 89.7% )远大于对照组 ( 12 .5 % ,P <0 .0 1)。结论 :DCC之CT表现有下肺纹理明显增粗、密度明显增高和末梢肺纹理明显延伸至胸膜面时 ,提示有HPS的CT证据。 Purpose: To explore CT changes and clinical significance of hepatopulmonary syndrome(HPS). Materials and Methods: We analysed CT data of 39 patients with DCC complicated HPS proved by clinic,laboratory and imaging examinations and 40 age-matched control subjects,and DSA data in pulmonary arteries of 2 patients with DCC complicated HPS. We measured in right base of lung as follow: (1)diameter of the most great lung-marking,(2)mean density and(3)incidence of lung-marking extend to pleura. Results: In patients with HPS (0.44±0.09mm), the peripheral pulmonary vasculature was significantly dilated compared with that in control subjects(0.44±0.09mm, 0.31±0.08mm;u=6.5, P< 0.01). In mean density there were a significant difference(u=2.26, 0.05>P>0.01)between HPS group(-671.4±92.4Hu) and control group (-710.1±54.7Hu).In frequency of lung-marking extend to pleura HPS group was significantly higher than that control group(89.7%, 12.5%; u=6.89, P<0.01). Conclusion: In patients with DCC significantly dilated peripheral pulmonary vasculature, increasing density of pulmonary base and finding of lung-marking extend to pleura are CT evidences of complicated HPS.
出处 《中国医学影像学杂志》 CSCD 2004年第4期246-248,共3页 Chinese Journal of Medical Imaging
关键词 肝肺综合征 CT表现 HPS 肝硬化 cirrhosis hepatopulmonary syndrome tomography, X-ray computed
  • 相关文献

参考文献8

二级参考文献12

  • 1[6]Lange PA, Stoller JK. The hepatopulmonary syndrome. Effect of liver transplantation. Clin Chest Med, 1996,17(1):115-123. 被引量:1
  • 2[7]Rolla G, Brussino L, Bucca C. The hepatopulmonary syndrome. Forum (Genova), 1998,8(1):84-92. 被引量:1
  • 3[8]Rodriguez-Roisin R, Roca J. Hepatopulmonary syndrome: the paradigm of liver- induced hypoxaemia. Baillieres Clin Gastroenterol, 1997,11(2):387-406. 被引量:1
  • 4[9]Meyer CA, White CS, Sherman KE. Diseases of the hepatopulmonary axis. Radiographics. 2000,20(3):687-698. 被引量:1
  • 5[1]Rowka MJ. Hepatopulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl, 2000,6(4 Suppl 1):S31-35. 被引量:1
  • 6[2]Muller C, Schenk P Hepatopulmonary syndrome. Wien Klin Wochenschr, 1999 ,111(9):339-347. 被引量:1
  • 7[3]Scott Vi, Dodson SF, Kang Y.The hepatopulmonary syndrome. Surg Clin North Am 1999,79(1):23-41. 被引量:1
  • 8[4]Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med, 1996,17(1):35-48. 被引量:1
  • 9[5]Krowka MJ, Porayko MK, Plevak DJ, et al. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc, 1997, 72(1):44-53. 被引量:1
  • 10吴孟超 杨广顺.大鼠肝硬化模型复制的研究[J].中华实验外科杂志,1984,1:145-147. 被引量:16

共引文献32

同被引文献36

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部